uniQure (QURE) Interest & Investment Income (2016 - 2026)
uniQure (QURE) recorded quarterly Interest & Investment Income of $5.2 million in Q1 2026, down 10.05% quarter-over-quarter from $5.8 million in Q4 2025, and up 26.7% on a YoY basis from $4.1 million in Q1 2025.
uniQure (QURE) Interest & Investment Income (2016 - 2026) Analysis & Trends
uniQure's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 26.7% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $18.1 million (down 5.07% YoY), while the FY2025 annual figure was $17.0 million, down 20.77% from the prior year.
- Interest & Investment Income was $5.2 million for Q1 2026 at uniQure, down from $5.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $7.5 million in Q3 2023 to a low of $35000.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $3.8 million across 5 years, with a median of $4.1 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 19117.95% in 2023, then tumbled 40.91% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $492000.0 in 2022, then jumped by 1357.11% to $7.2 million in 2023, then sank by 40.91% to $4.2 million in 2024, then jumped by 37.23% to $5.8 million in 2025, then dropped by 10.05% to $5.2 million in 2026.
- The last three Interest & Investment Income figures came in at $5.2 million (Q1 2026), $5.8 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 5.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 5.81 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 4.13 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 6.51 Mn |
| Dec 31, 2023 | 7.17 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 492,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 37,000.00 |